非アルコール性脂肪性肝炎（NASH）の世界市場：市場規模・現状・予測

• 英文タイトル：Global Non-alcoholic Steatohepatitis Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04979
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、非アルコール性脂肪性肝炎（NASH）の世界市場について調査・分析し、非アルコール性脂肪性肝炎（NASH）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他）、用途別（製薬及びCRO産業、病院、診断ラボ、学術研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の非アルコール性脂肪性肝炎（NASH）市場動向
・主要企業別マーケットシェア
・非アルコール性脂肪性肝炎（NASH）の種類別市場規模2014-2019
（血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他）
・非アルコール性脂肪性肝炎（NASH）の用途別市場規模2014-2019
（製薬及びCRO産業、病院、診断ラボ、学術研究機関）
・非アルコール性脂肪性肝炎（NASH）の北米市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）のヨーロッパ市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）の中国市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）の日本国内市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）の東南アジア市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）のインド市場：主要企業・種類別/用途別市場規模
・非アルコール性脂肪性肝炎（NASH）の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（GENFIT、Gilead Sciences (GILD)、AstraZeneca、Novartis、Bristol-Myers Squibb Company、Allergan、Novo Nordisk、Boehringer Ingelheim、Pfizer）
・非アルコール性脂肪性肝炎（NASH）の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Non-alcoholic steatohepatitis (NASH), is a common liver disease, often called as silent liver disease. It is asymptomatic until its later stages, and thus many patients are unaware of their condition.NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.
In 2018, the global Non-alcoholic Steatohepatitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-alcoholic Steatohepatitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-alcoholic Steatohepatitis development in United States, Europe and China.

The key players covered in this study
GENFIT
Gilead Sciences (GILD)
AstraZeneca
Novartis
Bristol-Myers Squibb Company
Allergan
Novo Nordisk
Boehringer Ingelheim
Pfizer

Market segment by Type, the product can be split into
Serum biomarkers
Hepatic fibrosis biomarkers
Apoptosis biomarkers
Oxidative stress biomarkers
Others

Market segment by Application, split into
Pharma & CRO Industry
Hospitals
Diagnostic Labs
Academic Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-alcoholic Steatohepatitis status, future forecast, growth opportunity, key market and key players.
To present the Non-alcoholic Steatohepatitis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-alcoholic Steatohepatitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-alcoholic Steatohepatitis Market Size Growth Rate by Type (2014-2025)
1.4.2 Serum biomarkers
1.4.3 Hepatic fibrosis biomarkers
1.4.4 Apoptosis biomarkers
1.4.5 Oxidative stress biomarkers
1.4.6 Others
1.5 Market by Application
1.5.1 Global Non-alcoholic Steatohepatitis Market Share by Application (2014-2025)
1.5.2 Pharma & CRO Industry
1.5.3 Hospitals
1.5.4 Diagnostic Labs
1.5.5 Academic Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-alcoholic Steatohepatitis Market Size
2.2 Non-alcoholic Steatohepatitis Growth Trends by Regions
2.2.1 Non-alcoholic Steatohepatitis Market Size by Regions (2014-2025)
2.2.2 Non-alcoholic Steatohepatitis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-alcoholic Steatohepatitis Market Size by Manufacturers
3.1.1 Global Non-alcoholic Steatohepatitis Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-alcoholic Steatohepatitis Market Concentration Ratio (CR5 and HHI)
3.2 Non-alcoholic Steatohepatitis Key Players Head office and Area Served
3.3 Key Players Non-alcoholic Steatohepatitis Product/Solution/Service
3.4 Date of Enter into Non-alcoholic Steatohepatitis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-alcoholic Steatohepatitis Market Size by Type (2014-2019)
4.2 Global Non-alcoholic Steatohepatitis Market Size by Application (2014-2019)

5 United States
5.1 United States Non-alcoholic Steatohepatitis Market Size (2014-2019)
5.2 Non-alcoholic Steatohepatitis Key Players in United States
5.3 United States Non-alcoholic Steatohepatitis Market Size by Type
5.4 United States Non-alcoholic Steatohepatitis Market Size by Application

6 Europe
6.1 Europe Non-alcoholic Steatohepatitis Market Size (2014-2019)
6.2 Non-alcoholic Steatohepatitis Key Players in Europe
6.3 Europe Non-alcoholic Steatohepatitis Market Size by Type
6.4 Europe Non-alcoholic Steatohepatitis Market Size by Application

7 China
7.1 China Non-alcoholic Steatohepatitis Market Size (2014-2019)
7.2 Non-alcoholic Steatohepatitis Key Players in China
7.3 China Non-alcoholic Steatohepatitis Market Size by Type
7.4 China Non-alcoholic Steatohepatitis Market Size by Application

8 Japan
8.1 Japan Non-alcoholic Steatohepatitis Market Size (2014-2019)
8.2 Non-alcoholic Steatohepatitis Key Players in Japan
8.3 Japan Non-alcoholic Steatohepatitis Market Size by Type
8.4 Japan Non-alcoholic Steatohepatitis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-alcoholic Steatohepatitis Market Size (2014-2019)
9.2 Non-alcoholic Steatohepatitis Key Players in Southeast Asia
9.3 Southeast Asia Non-alcoholic Steatohepatitis Market Size by Type
9.4 Southeast Asia Non-alcoholic Steatohepatitis Market Size by Application

10 India
10.1 India Non-alcoholic Steatohepatitis Market Size (2014-2019)
10.2 Non-alcoholic Steatohepatitis Key Players in India
10.3 India Non-alcoholic Steatohepatitis Market Size by Type
10.4 India Non-alcoholic Steatohepatitis Market Size by Application

11 Central & South America
11.1 Central & South America Non-alcoholic Steatohepatitis Market Size (2014-2019)
11.2 Non-alcoholic Steatohepatitis Key Players in Central & South America
11.3 Central & South America Non-alcoholic Steatohepatitis Market Size by Type
11.4 Central & South America Non-alcoholic Steatohepatitis Market Size by Application

12 International Players Profiles
12.1 GENFIT
12.1.1 GENFIT Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-alcoholic Steatohepatitis Introduction
12.1.4 GENFIT Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.1.5 GENFIT Recent Development
12.2 Gilead Sciences (GILD)
12.2.1 Gilead Sciences (GILD) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-alcoholic Steatohepatitis Introduction
12.2.4 Gilead Sciences (GILD) Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.2.5 Gilead Sciences (GILD) Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-alcoholic Steatohepatitis Introduction
12.3.4 AstraZeneca Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-alcoholic Steatohepatitis Introduction
12.4.4 Novartis Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-alcoholic Steatohepatitis Introduction
12.5.4 Bristol-Myers Squibb Company Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-alcoholic Steatohepatitis Introduction
12.6.4 Allergan Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.6.5 Allergan Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-alcoholic Steatohepatitis Introduction
12.7.4 Novo Nordisk Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.7.5 Novo Nordisk Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-alcoholic Steatohepatitis Introduction
12.8.4 Boehringer Ingelheim Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.8.5 Boehringer Ingelheim Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-alcoholic Steatohepatitis Introduction
12.9.4 Pfizer Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)
12.9.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-alcoholic Steatohepatitis Key Market Segments
Table Key Players Non-alcoholic Steatohepatitis Covered
Table Global Non-alcoholic Steatohepatitis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-alcoholic Steatohepatitis Market Size Market Share by Type 2014-2025
Figure Serum biomarkers Figures
Table Key Players of Serum biomarkers
Figure Hepatic fibrosis biomarkers Figures
Table Key Players of Hepatic fibrosis biomarkers
Figure Apoptosis biomarkers Figures
Table Key Players of Apoptosis biomarkers
Figure Oxidative stress biomarkers Figures
Table Key Players of Oxidative stress biomarkers
Figure Others Figures
Table Key Players of Others
Table Global Non-alcoholic Steatohepatitis Market Size Growth by Application 2014-2025 (Million US$)
Figure Pharma & CRO Industry Case Studies
Figure Hospitals Case Studies
Figure Diagnostic Labs Case Studies
Figure Academic Research Institutes Case Studies
Figure Non-alcoholic Steatohepatitis Report Years Considered
Table Global Non-alcoholic Steatohepatitis Market Size 2014-2025 (Million US$)
Figure Global Non-alcoholic Steatohepatitis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Size by Regions 2014-2025 (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Size by Regions 2014-2019 (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Share by Regions 2014-2019
Figure Global Non-alcoholic Steatohepatitis Market Share by Regions 2014-2019
Figure Global Non-alcoholic Steatohepatitis Market Share by Regions 2019
Table Market Top Trends
Table Global Non-alcoholic Steatohepatitis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Share by Manufacturers (2014-2019)
Figure Global Non-alcoholic Steatohepatitis Market Share by Manufacturers in 2018
Table Global Non-alcoholic Steatohepatitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-alcoholic Steatohepatitis Product/Solution/Service
Table Date of Enter into Non-alcoholic Steatohepatitis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Size Share by Type (2014-2019)
Figure Global Non-alcoholic Steatohepatitis Market Size Market Share by Type (2014-2019)
Table Global Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table Global Non-alcoholic Steatohepatitis Market Size Share by Application (2014-2019)
Figure Global Non-alcoholic Steatohepatitis Market Size Market Share by Application (2014-2019)
Figure Global Non-alcoholic Steatohepatitis Revenue Market Share by Application in 2018
Figure United States Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table United States Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table United States Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table United States Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table United States Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table United States Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table United States Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure Europe Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table Europe Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table Europe Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table Europe Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table Europe Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure China Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table China Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table China Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table China Non-alcoholic Steatohepatitis Market Size by Type (2014-20189) (Million US$)
Table China Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table China Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table China Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure Japan Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table Japan Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table Japan Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table Japan Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table Japan Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure Southeast Asia Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table Southeast Asia Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table Southeast Asia Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure India Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table India Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table India Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table India Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table India Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table India Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table India Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Figure Central & South America Non-alcoholic Steatohepatitis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-alcoholic Steatohepatitis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-alcoholic Steatohepatitis Market Share (2018-2019)
Table Central & South America Non-alcoholic Steatohepatitis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-alcoholic Steatohepatitis Market Share by Type (2014-2019)
Table Central & South America Non-alcoholic Steatohepatitis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-alcoholic Steatohepatitis Market Share by Application (2014-2019)
Table GENFIT Company Details
Table GENFIT Revenue in Non-alcoholic Steatohepatitis Business (2014-2019) (Million US$)
Figure GENFIT Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table GENFIT Recent Development
Table Gilead Sciences (GILD) Company Details
Table Gilead Sciences (GILD) Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Gilead Sciences (GILD) Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Gilead Sciences (GILD) Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Allergan Company Details
Table Allergan Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Allergan Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Novo Nordisk Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Non-alcoholic Steatohepatitis Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2014-2019)
Table Pfizer Recent Development
Table Global Non-alcoholic Steatohepatitis Market Size by Regions (Million US$) 2019-2025
Figure Global Non-alcoholic Steatohepatitis Market Size Share by Regions (2019-2025)
Figure Global Non-alcoholic Steatohepatitis Market Size Share by Regions in 2025
Figure United States Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure China Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure India Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-alcoholic Steatohepatitis Market Size Forecast (2019-2025)(Million USD)
Table Global Non-alcoholic Steatohepatitis Market Size by Product (2019-2025) (Million US$)
Figure Global Non-alcoholic Steatohepatitis Market Size by Product (2019-2025)
Figure Global Non-alcoholic Steatohepatitis Market Size by Product in 2025
Table Global Non-alcoholic Steatohepatitis Market Size by Application (2019-2025) (Million US$)
Figure Global Non-alcoholic Steatohepatitis Market Size by Application (2019-2025)
Figure Global Non-alcoholic Steatohepatitis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

非アルコール性脂肪性肝炎（NASH）の世界市場：市場規模・現状・予測

Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2019-2025
QYR9ST03956 2019年9月2日 91Pages
※当調査レポートでは、非アルコール性脂肪性肝炎（NASH）の世界市場について調査・分析し、非アルコール性脂肪性肝炎（NASH）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビタミンE、ピオグリタゾ...

アルコール性肝炎治療薬の世界市場：市場規模・現状・予測

Global Alcoholic Hepatitis Treatment Market Size, Status and Forecast 2019-2025
QYR9ST02211 2019年9月2日 97Pages
※当調査レポートでは、アルコール性肝炎治療薬の世界市場について調査・分析し、アルコール性肝炎治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コルチコステロイド、キサンチン誘導体、その他）、用途...

非アルコール性脂肪性肝疾患治療の世界市場：市場規模・現状・予測

Global Non Alcoholic Fatty Liver Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST03695 2019年9月2日 90Pages
※当調査レポートでは、非アルコール性脂肪性肝疾患治療の世界市場について調査・分析し、非アルコール性脂肪性肝疾患治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（酸化防止剤、チアゾリジンジオン、ビグ...

アルコール性肝炎治療薬の世界市場：市場規模・現状・予測

Global Alcoholic Hepatitis Therapeutic Market Size, Status and Forecast 2019-2025
QYR9ST04095 2019年9月2日 90Pages
※当調査レポートでは、アルコール性肝炎治療薬の世界市場について調査・分析し、アルコール性肝炎治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コ...

ノンアルコール飲料フレーバーシステムの世界市場：市場規模・現状・予測

Global Non-Alcoholic Beverage Flavoring System Market Size, Status and Forecast 2019-2025
QYR9ST05319 2019年9月2日 97Pages
※当調査レポートでは、ノンアルコール飲料フレーバーシステムの世界市場について調査・分析し、ノンアルコール飲料フレーバーシステムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フレーバーエンハンサー、...

アルコール飲料フレーバーシステムの世界市場：市場規模・現状・予測

Global Alcoholic Beverage Flavoring System Market Size, Status and Forecast 2019-2025
QYR9ST05232 2019年9月2日 98Pages
※当調査レポートでは、アルコール飲料フレーバーシステムの世界市場について調査・分析し、アルコール飲料フレーバーシステムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フレーバーエンハンサー、フレーバ...

ノンアルコール飲料フレーバーシステムの世界市場：市場規模・現状・予測

アルコール飲料フレーバーシステムの世界市場：市場規模・現状・予測

体輪郭の世界市場：市場規模・現状・予測

Global Body Contouring Market Size, Status and Forecast 2019-2025
QYR9ST04738 2019年9月2日 99Pages
※当調査レポートでは、体輪郭の世界市場について調査・分析し、体輪郭の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非侵襲的・最小限侵襲的体輪郭、侵襲的体輪郭）、用途別（臨床研究機関、病院、メディ...

分子診断（MDx）の世界市場：市場規模・現状・予測

Global Molecular Diagnosis (MDx) Market Size, Status and Forecast 2019-2025
QYR9ST14559 2019年9月10日 98Pages
※当調査レポートでは、分子診断（MDx）の世界市場について調査・分析し、分子診断（MDx）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非侵襲的出生前検査（NIPT）、診断とともに、液体生検、その...

血清がんバイオマーカーの世界市場：インサイト・予測 Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within…
ゲノミクスバイオマーカーの世界市場：市場規模・現状・予測 A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
予測バイオマーカーの世界市場：市場規模・現状・予測 Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. In 2…
予測バイオマーカーの世界市場：市場規模・現状・予測 Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. In 2…
非アルコール性脂肪性肝炎（NASH）の世界市場：市場規模・現状・予測 Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major fac…